Is Sunscreen a Drug? The OTC Monograph, Explained

Yes. Sunscreen sold in the US is an over-the-counter (OTC) drug, regulated under the FDA’s sunscreen monograph rather than as a cosmetic. That means approved active ingredients at approved concentrations, a Drug Facts panel instead of a cosmetic ingredient list, and a manufacturer that can document compliance the way any drug product requires, not just a personal-care one.

What does “OTC monograph” actually mean?

A monograph is FDA’s rulebook for a category of nonprescription drug: which active ingredients are allowed, at what concentrations, with what labeling and testing requirements. Sunscreen has its own monograph, separate from the ones covering acne treatments or external analgesics. FDA’s sunscreen drug facts and labeling page explains the category from the agency’s side. A brand that skips this step and treats sunscreen like a cosmetic formulation project is missing the actual regulatory bar.

What does the monograph require of the formula?

Only approved UV filters, at approved concentration ranges, can go into a monograph sunscreen. You can’t substitute an unapproved filter no matter how it performs. FDA’s June 2026 announcement expanding sunscreen active ingredient options covers the first monograph change to add a new filter in roughly two decades, which is a useful illustration of how infrequently this list moves and how deliberate a brand’s filter choice needs to be. Our mineral vs. chemical sunscreen guide covers what changes at the formulation bench once you’ve picked a filter system.

How is that different from a cosmetic requirement?

What does it require of the manufacturer?

The facility filling your sunscreen needs FDA drug establishment registration and has to manufacture to 21 CFR 210/211, the same current-good-manufacturing-practice framework that applies to other OTC drugs, not the lighter cosmetic GMP guidance. Ask directly whether a prospective manufacturer runs sunscreen under that standard today, and for how long, rather than assuming a personal-care manufacturer can simply add it. Our buyer’s checklist for choosing a contract manufacturer has the fuller list of questions to bring to that conversation.

Does the monograph cover SPF and broad-spectrum testing too?

The monograph sets the active-ingredient and labeling rules; SPF and broad-spectrum claims still need to be supported by testing on the finished formula. That testing is a separate project step, with its own timeline, from choosing a monograph-compliant filter system. Our sunscreen testing guide lays out what that involves and how starting from an already-tested formula changes the schedule.

What should a brand owner actually do with this?

Treat “is this an OTC drug” as the first regulatory question on a sunscreen brief, before formulation preferences or packaging. Confirm your manufacturer’s current monograph experience and FDA registration in writing, and ask what documentation accompanies each batch. If you’re moving an existing sunscreen to a new manufacturer, raise the drug requirements at the very start of that conversation. Our formula-transfer guide explains why.

InSpec Solutions is an FDA-registered sunscreen manufacturer running mineral and chemical SPF under the OTC monograph, in lotion, stick, and continuous-spray formats, at one facility. Explore sunscreen manufacturing or send your brief to start the regulatory and format conversation together.